PeptiDream Inc (4587.T)
Latest Key Developments (Source: Significant Developments)
Sept 25(Reuters) - PeptiDream Inc <4587.T>:Says it has entered into a broad-based multi-target discovery and development agreement with Santen Pharmaceutical Co Ltd <<<4536.T>>>. Full Article
TOKYO Japanese drug-discovery company PeptiDream Inc said on Friday it would collaborate with Merck & Co in developing COVID-19 therapies.